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Summary
 
The pre-B cell receptor is a key checkpoint regulator in developing B cells. Early events that
are controlled by the pre-B cell receptor include positive selection for cells express membrane
immunoglobulin heavy chains and negative selection against cells expressing truncated immu-
noglobulins that lack a complete variable region (D
 
m
 
). Positive selection is known to be medi-
ated by membrane immunoglobulin heavy chains through Ig
 
a
 
-Ig
 
b
 
, whereas the mechanism
for counterselection against D
 
m
 
 has not been determined. We have examined the role of the
Ig
 
a
 
-Ig
 
b
 
 signal transducers in counterselection against D
 
m
 
 using mice that lack Ig
 
b
 
. We found
that D
 
m
 
 expression is not selected against in developing B cells in Ig
 
b
 
 mutant mice. Thus, the
molecular mechanism for counterselection against D
 
m
 
 in pre-B cells resembles positive selec-
tion in that it requires interaction between mD
 
m
 
 and Ig
 
a
 
-Ig
 
b
 
.
 
T
 
he object of B lymphocyte development is to produce
cells with a diverse group of clonally restricted antigen
receptors that are not self reactive (1). Antigen receptor di-
versification is achieved through regulated genomic rear-
rangements that result in the random assembly of Ig gene
segments into productive transcription units (2, 3). These
gene rearrangements are in large part regulated by the pre-
B cell receptor (BCR)
 
1
 
.
B cells undergoing Ig heavy chain gene rearrangements
(pre-B) can express at least two types of BCRs. One form
of the receptor is composed of membrane immunoglobulin
heavy chain (mIg
 
m
 
), 
 
l
 
5, V–pre-B, and Ig
 
a
 
-Ig
 
b
 
, and is re-
ferred to as the pre-BCR (4–6). A second form of the pre-
B cell receptor, known as the D
 
m
 
 pre-BCR (7), is found
only in pre-B1 cells (8) and contains truncated mIg
 
m
 
 chains
lacking a V
 
H
 
 domain (mD
 
m
 
). mD
 
m
 
 is produced by Ig genes
that have rearranged DJ
 
H
 
 gene segments in reading frame
(RF) 2 producing an in-frame start codon and a truncated
transcription unit (7). Like authentic mIg
 
m
 
, mD
 
m
 
 is a mem-
brane protein that forms a complex with 
 
l
 
5, V–pre-B, and
Ig
 
a
 
-Ig
 
b
 
, and in tissue culture cell lines the D
 
m
 
 pre-BCR
can activate cellular signaling responses (9–14). But despite
its ability to activate nonreceptor tyrosine kinases, D
 
m
 
 pre-
BCR producing pre-B cells are selected against by a pro-
cess that is mediated through the transmembrane domain of
the mD
 
m
 
 protein (15). In contrast, pre-B cells that express
intact mIg
 
m
 
 containing pre-BCRs are positively selected.
Counterselection is reflected in the relative lack of mature
B cells that express mIg
 
m
 
 in RF2 (15–17). The mechanism
by which mD
 
m
 
 activates counterselection has not been de-
fined, but is known to require expression of syk (18). Here
we report on experiments showing that Ig
 
b
 
 is essential for
counterselection against mD
 
m
 
 in vivo.
 
Materials and Methods
 
Mice.
 
Ig
 
b
 
2
 
/
 
2
 
, mIg
 
m
 
, and Bcl-2 transgenic strains have been
previously described and were maintained by backcrossing with
BALB/c mice under specific pathogen-free conditions (19–21).
All experiments were performed with 4–8-wk-old female mice.
 
Fluorescence Analysis and Cell Sorting.
 
Single cell suspensions pre-
pared from bone marrow or spleen were stained with PE-labeled
anti-B220 and FITC-labeled anti-CD43 (PharMingen, San Di-
ego, CA) or FITC-labeled anti-IgM, and analyzed on a FACScan
 
Ò
 
.
For cell sorting, bone marrow cells from four to six mice were
stained with the same reagents and separated on a FACSvantage
 
Ò
 
.
CD43
 
1
 
B220
 
2
 
 and CD43
 
1
 
B220
 
1
 
 cells were collected based on
gating with RAG-1
 
2
 
/
 
2
 
 controls.
 
DNA and PCR.
 
Total bone marrow DNA was prepared for
PCR as previously described (22). DNA from sorted cells was
prepared for PCR in agarose plugs (23). Primers for V
 
H
 
–DJ
 
H
 
 and
D
 
H
 
–J
 
H
 
 rearrangement were as in reference 22; these primers are
mouse specific and do not detect the human Ig
 
m
 
 transgene. All
experiments were performed a minimum of three times with two
independently derived DNA samples. Nonrearranging Ig gene
intervening sequences were amplified in parallel with other reac-
tions and used as a loading control (22). Amplified DNA was vi-
sualized after transfer to nylon membranes by hybridization with
a 6-kb EcoR1 fragment that spans the mouse J
 
H
 
 region.
 
Isolation and Sequencing of V
 
H
 
–DJ
 
H
 
 and D
 
H
 
–J
 
H
 
 Joints.
 
A J
 
H
 
4 primer
was combined with either a D
 
H
 
 primer or a VHJ558L primer to
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; mIg
 
m
 
, membrane
immunoglobulin heavy chain; RF, reading frame.
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a
 
–Ig
 
b
 
amplify DJ
 
H
 
 and VDJ
 
H
 
 rearrangements, respectively. The primers
were: (
 
a
 
) J
 
H
 
4, ACGGATCCGGTGACTGAGGTTCCT; (
 
b
 
) D
 
H
 
,
ACAAGCTTCAAAGCACAATGCCTGGCT; and (
 
c
 
) VHJ558L,
GCGAAGCTTA(A,G)GCCTGGG(A,G)CTTCAGTGAAG. PCR
amplification for DJ
 
H
 
 joints was for 35 cycles of 0.5 min at 94
 
8
 
C,
and 2 min at 72
 
8
 
C; for VDJ
 
H
 
 joints, it was for 0.5 min at 94
 
8
 
C, 1
min at 68
 
8
 
C, and 1.5 min at 72
 
8
 
C. PCR products were purified
by agarose gel electrophoresis, subcloned into pBluescript, sequenced
using an Applied Biosystems (Foster City, CA) DNA sequencing
kit, and analyzed on a genetic analyzer (ABI-310; Applied Biosys-
tems).
 
Results
 
mIgM Cannot Induce the Pre-B Cell Transition or Allelic Ex-
clusion in the Absence of Ig
 
b
 
.
 
Expression of Ig
 
b
 
 is required
for B cells to efficiently complete Ig V
 
H
 
 to DJ
 
H
 
 gene rear-
rangements (19). B cells in Ig
 
b
 
2
 
/
 
2
 
 mice fail to express nor-
mal levels of mIg
 
m
 
, and B cell development is arrested at
the CD43
 
1
 
B220
 
1
 
 pre-B1 stage (19). A similar celltype spe-
cific developmental arrest is also found in mice that carry a
mutation in the transmembrane domain of mIg
 
m
 
 (24), and
mice that fail to complete Ig V(D)J recombination (25–29).
In view of the abnormally low levels of mIg
 
m
 
 in Ig
 
b
 
2
 
/
 
2
 
mice, failed pre-B cell development might simply be due to
lack of Ig expression.
To determine whether mIg
 
m
 
 could induce the pre-B
cell transition in the absence of Ig
 
b
 
, we introduced a pro-
ductively rearranged immunoglobulin gene (20) into the
Ig
 
b
 
2
 
/
 
2
 
 background (TG.m
 
m
 
 Ig
 
b
 
2
 
/
 
2
 
). We then measured
B cell development by staining bone marrow cells with anti-
CD43 and anti-B220 monoclonal antibodies (30). We
found that expression of a pre-rearranged Ig transgene was
not sufficient to activate the pre-B cell transition in the ab-
sence of Ig
 
b
 
 (Fig. 1). TG.mm Igb2/2 B cells did not de-
velop past the CD431B2201 pre-B cell stage (Fig. 1). In
control experiments, the same mIgm transgene did induce
the appearance of more mature CD432B2201 pre-B cells
in a RAG2/2 mutant background where B cell develop-
ment was similarly arrested at the CD431B2201 stage (20,
25, 26; data not shown). We conclude that in the absence
of Igb, a productively rearranged mIgm is unable to acti-
vate the pre-B cell transition.
Allelic exclusion is established as early as the CD431
B2201 stage of B cell development (31–33). This early
stage of development is found in the bone marrow of Igb2/2
mice (19). However, we were initially unable to measure
allelic exclusion in Igb mutant mice due to the low effi-
ciency of complete Ig VH to DJH gene rearrangements and
absence of surface Igm expression (19). To determine
whether expression of mIgm could activate allelic exclusion
in TG.mm Igb2/2 mice, we measured inhibition of VH to
DJH gene rearrangements by PCR (34). In controls, the
mIgm transgene inhibited VH to DJH gene rearrangement
(22), but the same transgene had no effect in the Igb2/2
background (Fig. 2). We had previously shown that the cy-
toplasmic domains of Iga and Igb are sufficient to activate
allelic exclusion (20, 35). The finding that mIgm is unable
to induce allelic exclusion in the absence of Igb suggests
that Igb is essential for allelic exclusion.
Figure 1. Flow cytometric analysis
of spleen (Spl) and bone marrow cells
(BM) from Igb2/2, transgenic, and
wild-type mice. Single-cell suspen-
sions from lymphoid organs of 6-wk-
old mice were prepared and analyzed
on FACScanÒ. Bone marrow cells
were stained with PE–anti-B220 and
FITC–anti-CD43. Spleen cells were
stained with FITC–anti-IgM and PE–
anti-B220. The lymphocyte popula-
tion was gated according to standard
forward- and side-scatter values. The
numbers in each quadrant represent
the percentages of gated lymphocytes.
WT, wild type; RAG2/2, RAG-1
mutant; Igb2/2, Igb mutant; Igb2/2
m.TG, Igb mutant, mIgm, transgenic.
Figure 2. Ig gene rearrangements in Igb2/2, transgenic, and wild-type
mice. Bone marrow DNA from 6-wk-old mice was amplified with
VH558L, VH7183 (not shown), or DH and JH2 primers. Control primers
were from the J-CH1 intervening sequence (IVS) (22).2081 Gong et al.
Igb Is Required for RF2 Counterselection. Igs with DH
joined to JH in RF2 are rarely found in mature B cells (15–17).
Genetic experiments in mice have shown that counterse-
lection against RF2 requires the transmembrane domain of
mIgm and the syk tyrosine kinase (15, 18). To determine
whether counterselection is mediated through Igb, we se-
quenced DJH joints amplified from sorted CD431B2201
pre-B cells from Igb2/2 mice and controls. In control sam-
ples, only 10% of the DJH joints were in RF2 (Fig. 3),
which is in agreement with similar measurements per-
formed in other laboratories (15–17, 31–33). In contrast,
there was no counterselection in the bone marrow cells of
Igb2/2 mice; 13 out of 30 DJH joints were in RF2 with the
remainder being distributed in RF1 and 3 (Fig. 3). Thus, in
the absence of Igb, there was no RF2 counterselection at
the level of DJH rearrangements in CD431B2201 cells in
the bone marrow.
VH to DJH joining and counterselection are normally
completed in CD431B2201 pre-B cells (31–33), but in
Igb2/2 mice, VH to DJH joining is inefficient (19). To de-
termine whether RF2 was counterselected in the few Igb
mutant B cells that completed VH to DJH rearrangements,
we amplified and sequenced VHJ558L-DJH4 joints from
unfractionated bone marrow cells (Fig. 4). As with the DJH
joints, we found no evidence for counterselection against
RF2 in VDJH joints in Igb2/2 B cells. 10/33 VHJ558L-
DJH4 joints sequenced from Igb2/2 mice were in RF2. By
contrast, RF2 was only found in 1 of 11 mature Ig’s in the
controls. The VDJH and DJH Igb2/2 joints otherwise re-
sembled the wild type in the number of N and P nucle-
otides as well as in the extent of nucleotide deletion (Figs. 3
and 4). We conclude that there was no selection against
RF2 in the absence of Igb, and that the absence of Igb has
no significant impact on the mechanics of recombination as
measured by the variability of the joints.
Discussion
The transmembrane domain of mIgm is required to pro-
duce the signals that mediate several antigen-independent
events in developing B cells, including allelic exclusion and
the pre-B cell transition (24, 36–39). However, mIgm itself
is insufficient for signal transduction (40), and it requires
the Iga and Igb signaling proteins to activate B cell re-
sponses in vitro and in vivo.
The earliest developmental checkpoint regulated by Iga-
Igb appears to involve either activation of cellular compe-
tence to complete VH to DJH rearrangements, or positive
selection for cells that express mIgm (19). In the next phase
of the B cell pathway, the same transducers are necessary
(Fig. 2) and sufficient to produce the signals that activate al-
lelic exclusion and the pre-B cell transition (19, 20, 35, 41).
Figure 3. Nucleotide sequences of DH–JH joints from Igb2/2 and wild-type sorted bone marrow B cells. DH segment, N or P nucleotides, and JH4 seg-
ment sequences are shown. The number of DJH4 joints in DH RF 1, 2, or 3 are noted. Stop codons in DH segments are underlined.2082 Counterselection against Dm Is Mediated through Immunoglobulin (Ig)a–Igb
In the present report, we show that in addition to these
functions, Iga-Igb transducers are also necessary for nega-
tive selection against Dm.
Two models have been proposed to explain counterse-
lection against mDm. The first model states that mDm is
toxic, and that cells expressing this protein are deleted by a
mechanism that involves inhibition of proliferation (31). A
second theory postulates that Dm proteins produce the sig-
nal for heavy chain allelic exclusion and block the comple-
tion of productive heavy chain gene rearrangements (15).
According to this second model, cells expressing mDm are
then unable to continue along the B cell pathway. Support
for the active signaling model comes from three sets of ob-
servations: (a) that there is no counterselection in the ab-
sence of a Igm transmembrane exon (15); (b) that there is
no RF counterselection in the absence of syk (18); and (c)
that there is no counterselection in early CD431B2201 B
cell precursors in the absence of l5 (33). These experi-
ments partially define the receptor structure for counterse-
lection as composed of mDm associated with l5. Our ob-
servation that negative selection against Dm does not occur
in the absence of Igb supports the signaling model, and
identifies Iga-Igb as the transducers that activate coun-
terselection possibly by linking mDm to nonreceptor ty-
rosine kinases.
Why does the expression of the Dm pre-BCR lead to ar-
rested development, whereas mature mIgm in the same com-
plex activates positive selection in early B cells? Both signals
are produced in CD431B2201 pre-B cells, both require l5
(33, 39, 42), and the Iga-Igb coreceptors (19, 41), and both
are transmitted through a cascade that induces syk (18, 43).
One way to explain the difference between the cellular re-
sponse to mDm pre-BCR and mIgm pre-BCR expression
might be an inability of Dm to pair with conventional k or
l Ig light chains (14). According to this model, cells ex-
pressing mDm should be trapped in the CD432B2201 pre-
B cell compartment since B cell development can progress
to the CD432B2201 stage in the absence of conventional
light chains (44, 45). However, elegant single cell sorting
experiments have shown that mDm-producing cells are se-
lected against before this stage in CD431B2201 pre-B cells
(33, 42). Thus, the idea that abnormal pairing of mDm
with light chains is responsible for counterselection fails to
take into account the observation that counterselection
normally occurs independently of light chain gene rear-
rangements.
Two alternative explanations for the disparate cellular re-
sponses to the Dm pre-BCR and the mIgm pre-BCR are:
(a) that there are qualitative differences between signals
generated by a mDm and a mIgm receptor complex, and (b)
pre-B-I cells that contain DJH rearrangements are in a dif-
ferent stage of differentiation than pre-B-II cells that have
completed VDJH and express mIgm (8). An example of two
qualitatively distinct signals resulting in alternative biologic
responses has been found in the highly homologous TCR
receptor (46, 47). TCR interaction with ligand can pro-
duce either anergy or activation, depending on the affinity
of the TCR for the peptide-MHC complex (48). High af-
finity ligands that produce T cell responses fully activate
CD3 tyrosine phosphorylation, whereas peptides that in-
duce anergy bind with low affinity and induce a reduced
level of CD3 phosphorylation. The low level CD3 phos-
phorylation induced by the anergizing peptides is associated
with less than optimal ZAP-70 kinase activation (46, 47).
Less is known about the physiologic responses acti-
vated by Iga-Igb in developing B cells, but experiments
in transgenic mice have shown that early B cell develop-
ment requires tyrosine phosphorylation of Igb (20), and by
Figure 4. Nucleotide sequences of V(D)J (VH558L to DJH4) joints from Igb2/2 and wild-type bone marrow B cells. DH segment, N or P nucleotides,
and JH4 segment sequences are shown. The number of DJH4 joints in DH RF 1, 2, or 3 are noted. Stop codons in DH segments are underlined, and the
DH segments used (S) are indicated.2083 Gong et al.
inference, receptor cross-linking. Although the cytoplasmic
domains Iga and Igb appear to have redundant functions in
allelic exclusion and the pre-B cell transition (20, 35), nei-
ther Iga, (41) nor Igb (Papavasiliou, N., and M.C. Nus-
senzweig, manuscript in preparation) alone are able to fully
restore B cell development in the bone marrow, suggesting
that there are specific functions for Iga and Igb, or the Iga-
Igb heterodimer. Biochemical support for the idea that indi-
vidual coreceptors could have unique biologic functions
also comes from transfection experiments in B cell lines
(49–51) and from the observation that the cytoplasmic do-
mains of Iga and Igb bind to different sets of nonreceptor
tyrosine kinases (52).
We would like to propose that positive and negative se-
lection in developing B cells, like activation and anergy in
T cells, may be mediated by differential phosphorylation of
Iga and Igb in the pre-BCR. Given the requirement for
cross-linking in pre-BCR activation, the mechanism that
produces the proposed differential phosphorylation of the
mDm and mIgm pre-BCRs may be a function of their af-
finities for the cross-linker.
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